DE3681243D1 - Stabile formulierung biologisch aktiver proteine zur parenteralen injektion. - Google Patents
Stabile formulierung biologisch aktiver proteine zur parenteralen injektion.Info
- Publication number
- DE3681243D1 DE3681243D1 DE8686307397T DE3681243T DE3681243D1 DE 3681243 D1 DE3681243 D1 DE 3681243D1 DE 8686307397 T DE8686307397 T DE 8686307397T DE 3681243 T DE3681243 T DE 3681243T DE 3681243 D1 DE3681243 D1 DE 3681243D1
- Authority
- DE
- Germany
- Prior art keywords
- parenteral injection
- biologically active
- active proteins
- stable formulation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/780,551 US4816440A (en) | 1985-09-26 | 1985-09-26 | Stable formulation of biologically active proteins for parenteral injection |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3681243D1 true DE3681243D1 (de) | 1991-10-10 |
Family
ID=25119894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686307397T Expired - Fee Related DE3681243D1 (de) | 1985-09-26 | 1986-09-25 | Stabile formulierung biologisch aktiver proteine zur parenteralen injektion. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4816440A (de) |
EP (1) | EP0217645B1 (de) |
JP (1) | JPS6272625A (de) |
AT (1) | ATE66817T1 (de) |
AU (1) | AU590618B2 (de) |
CA (1) | CA1295245C (de) |
DE (1) | DE3681243D1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0645551B2 (ja) * | 1986-01-07 | 1994-06-15 | 塩野義製薬株式会社 | インタ−ロイキン−2組成物 |
DE3621828A1 (de) * | 1986-06-28 | 1988-01-14 | Biotest Pharma Gmbh | Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
US4973478A (en) * | 1987-07-20 | 1990-11-27 | Allelix Biopharmaceuticals, Inc. | Treating inflammation with hepatocyte stimulating factor interferon β2 |
NZ226799A (en) * | 1987-11-06 | 1991-08-27 | Oncogen | Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor |
US4965191A (en) * | 1988-02-12 | 1990-10-23 | Eastman Kodak Company | Lower alcohol sulfate wash solution, test kit and method for the determination of an immunological ligand |
US5198212A (en) * | 1988-10-31 | 1993-03-30 | University Of Lousville Research Foundation Incorporated | Method and compositions for treatment of trauma-associated sepsis with gamma interferon |
US5530100A (en) * | 1990-05-07 | 1996-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Methods for purification of recombinantly produced proteins |
US5830452A (en) * | 1990-11-20 | 1998-11-03 | Chiron Corporation | Method for enhancing the anti-tumor therapeutic index of interleukin-2 |
JPH0588553U (ja) * | 1991-10-04 | 1993-12-03 | チェン ロン−シウン | 浮玉自動オフ式点滴輸液管 |
FR2684878B1 (fr) * | 1991-12-12 | 1994-02-11 | Roussel Uclaf | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. |
US5545723A (en) * | 1994-03-15 | 1996-08-13 | Biogen Inc. | Muteins of IFN-β |
US5714371A (en) * | 1995-05-12 | 1998-02-03 | Schering Corporation | Method for refolding insoluble aggregates of hepatitis C virus protease |
JP4293497B2 (ja) | 1997-09-23 | 2009-07-08 | レントシュレール ビオテクノロジー ゲー・エム・ベー・ハー | インターフェロン−β液状組成物 |
US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US7582311B1 (en) | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
EP1935431A3 (de) | 2000-05-15 | 2008-08-13 | Health Research, Inc. | Krebsbehandlungen unter Verwendung einer Kombination aus einem HER2-Antikörper und Interleukin-2 |
US7544354B2 (en) * | 2000-10-27 | 2009-06-09 | Novartis Vaccines And Diagnostics | Methods of protein purification and recovery |
IL155788A0 (en) | 2000-11-07 | 2003-12-23 | Chiron Corp | Stabilized interferon compositions |
US6887462B2 (en) | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
AU2002308456B2 (en) * | 2001-04-18 | 2005-12-22 | Prometic Pharma Smt Limited | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
DE60317822D1 (de) * | 2002-10-29 | 2008-01-10 | Alza Corp | Stabilisierte feste polypeptidpartikel |
EP1628618A4 (de) * | 2002-12-26 | 2009-09-09 | Mountain View Pharmaceuticals | Polymerkonjugate aus zytokinen, chemokinen, wachstumsfaktoren, polypeptidhormonen und antagonisten davon mit konservierter rezeptorbindender aktivität |
TWI406672B (zh) * | 2002-12-26 | 2013-09-01 | Mountain View Pharmaceuticals | 生物效力增進的β干擾素聚合物共軛體 |
ES2379267T3 (es) * | 2003-10-23 | 2012-04-24 | Novartis Vaccines And Diagnostics, Inc. | Composiciones estabilizadas |
JP4746552B2 (ja) | 2003-11-04 | 2011-08-10 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 自己免疫疾患および炎症性疾患ならびに臓器移植拒絶の処置のためのアンタゴニスト抗cd40抗体の使用 |
KR20080030956A (ko) * | 2005-05-19 | 2008-04-07 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 개선된 조절 발현 체계를 사용한 질병의 치료 |
TW200716749A (en) * | 2005-05-19 | 2007-05-01 | Schering Ag | Interferon-beta gene therapy using an improved, regulated expression system |
US20080076729A1 (en) * | 2005-05-19 | 2008-03-27 | Schering Aktiengesellachaft | Interferon-beta gene therapy using an improved, regulated expression system |
US20070179113A1 (en) * | 2005-05-19 | 2007-08-02 | Schering Aktiengesellachaft | GM-CSF gene therapy for Crohn's disease using an improved regulated expression system |
WO2009045553A1 (en) * | 2007-10-05 | 2009-04-09 | Barofold, Inc. | High pressure treatment of aggregated interferons |
DE102012101864A1 (de) * | 2012-03-06 | 2013-09-12 | Gramme-Revit Gmbh | Mittel zur Behandlung von Allergien und anderen Erkrankungen |
EP3596108A4 (de) | 2017-03-15 | 2020-12-23 | Pandion Operations, Inc. | Gezielte immuntoleranz |
KR20200010354A (ko) | 2017-05-24 | 2020-01-30 | 팬디온 테라퓨틱스, 인코포레이티드 | 표적화된 면역관용 |
US10174092B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
KR20220035333A (ko) | 2019-05-20 | 2022-03-22 | 팬디온 오퍼레이션스, 인코포레이티드 | Madcam 표적 면역관용 |
WO2021168079A1 (en) | 2020-02-21 | 2021-08-26 | Pandion Operations, Inc. | Tissue targeted immunotolerance with a cd39 effector |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3658970A (en) * | 1969-07-23 | 1972-04-25 | John Mcclure Carroll | Injectable lauric acid |
US3667929A (en) * | 1969-07-30 | 1972-06-06 | George W Fleming Jr | Method of effecting dissolution of solutes in water and compositions therefor |
CA1113926A (en) * | 1975-08-27 | 1981-12-08 | Johannes Van Der Vies | Pharmaceutical preparation adapted for oral administration |
US4331653A (en) * | 1977-08-18 | 1982-05-25 | Robert Brown | Composition for a topical cream for curtailing bleeding and treating skin disorders |
JPS56104812A (en) * | 1980-01-23 | 1981-08-20 | Sankyo Co Ltd | Production of cephalosporin compound preparation for rectal infusion |
JPS5780314A (en) * | 1980-11-09 | 1982-05-19 | Kyoto Yakuhin Kogyo Kk | Pharmaceutical preparation to be medicated to rectum |
JPS5788126A (en) * | 1980-11-19 | 1982-06-01 | Kyoto Yakuhin Kogyo Kk | Agent for promoting peroral and transvaginal absorption and preparation containing the same |
JPS58116498A (ja) * | 1981-12-28 | 1983-07-11 | Takeda Chem Ind Ltd | Il‐2をコードする新規伝令rnaの製造法 |
US4450103A (en) * | 1982-03-01 | 1984-05-22 | Cetus Corporation | Process for recovering human IFN-β from a transformed microorganism |
DE3377363D1 (en) * | 1982-03-31 | 1988-08-18 | Ajinomoto Kk | Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells |
US4462940A (en) * | 1982-09-23 | 1984-07-31 | Cetus Corporation | Process for the recovery of human β-interferon-like polypeptides |
US4463940A (en) * | 1982-10-18 | 1984-08-07 | Mock Russell V | Apparatus and method for continuous stacking of signatures using opposed floating conveyors |
EP0127426A1 (de) * | 1983-05-23 | 1984-12-05 | Takeda Chemical Industries, Ltd. | Perkutane pharmazeutische Zusammensetzungen zur äusserlichen Anwendung |
US4604377A (en) * | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
-
1985
- 1985-09-26 US US06/780,551 patent/US4816440A/en not_active Expired - Lifetime
-
1986
- 1986-09-02 CA CA000517300A patent/CA1295245C/en not_active Expired - Fee Related
- 1986-09-25 EP EP86307397A patent/EP0217645B1/de not_active Expired - Lifetime
- 1986-09-25 AT AT86307397T patent/ATE66817T1/de not_active IP Right Cessation
- 1986-09-25 DE DE8686307397T patent/DE3681243D1/de not_active Expired - Fee Related
- 1986-09-26 AU AU63182/86A patent/AU590618B2/en not_active Ceased
- 1986-09-26 JP JP61226310A patent/JPS6272625A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1295245C (en) | 1992-02-04 |
EP0217645A2 (de) | 1987-04-08 |
US4816440A (en) | 1989-03-28 |
AU590618B2 (en) | 1989-11-09 |
EP0217645A3 (en) | 1987-09-23 |
AU6318286A (en) | 1987-04-02 |
EP0217645B1 (de) | 1991-09-04 |
JPS6272625A (ja) | 1987-04-03 |
ATE66817T1 (de) | 1991-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE66817T1 (de) | Stabile formulierung biologisch aktiver proteine zur parenteralen injektion. | |
DE3689870D1 (de) | Formulierung für rekombinantes beta-Interferon, Verfahren zur Gewinnung und Stabilisierung des beta-Interferons und dessen Verwendung. | |
ATE66614T1 (de) | Insulinzubereitung fuer nicht-parenterale verabreichung. | |
ATE74512T1 (de) | Pharmazeutische zusammensetzungen von rekombinanten interleukin-2 und herstellungsverfahren. | |
FI874706A0 (fi) | Menetelmä glykosyloimattoman yhdistelmäinterferoni- :n stabiilien, farmaseuttisten koostumusten valmistamiseksi | |
DE69531314D1 (de) | Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen | |
PH22556A (en) | Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof | |
MY128629A (en) | Stabilized interleukin 2 | |
FI870219A (fi) | Hypoglykemiska tiazolidindioner. | |
ES2009216A6 (es) | Metodo de preparar un derivado de interleucina-lalfa. | |
ATE96807T1 (de) | Rcrf und aehnliche verbindungen. | |
ATE44652T1 (de) | Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. | |
IT1187828B (it) | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi | |
SE8503097D0 (sv) | Glutaminsyra- och asparginsyraderivat | |
FI882605A (fi) | Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta | |
NO955126D0 (no) | Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav | |
ATE79267T1 (de) | Stabilisierung eines fuer therapeutische zwecke bestimmten interleukin-2-praeparates. | |
DK0641216T3 (da) | Farmaceutisk præparat indeholdende IL-6 | |
DK425487A (da) | Pharmaceutisk aktive derivater af glutamin- og asparginsyre | |
NO863026D0 (no) | Fenyletanolaminderivater-preparater med kontinuerlig avgivelse. | |
EP0219839A3 (de) | Derivat des Interleukin-2, seine Herstellung und Verwendung | |
JPS6479125A (en) | Antitumor agent | |
ZA891784B (en) | Peptides with pharmaceutical activity | |
SU1387399A1 (ru) | Питательная среда для культивирования лептоспир | |
ATE54941T1 (de) | Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |